Research - Toulouse, Occitanie, France
Cell-Easy's team is committed to its customers to develop & produce ATMPs for clinical advanced therapies. Our ambition combines analytical and process innovations to provide cGMP cells with extended characterization (safety, identity, and performance).Cell-Easy's experience in stem cells has grown from its original ambition: to make cell therapy accessible to as many patients as possible, by combining an allogeneic approach with a high-performance culture process. Our MSC production process has been designed using a QbD approach and an economic study (simulation of the manufacturing cost model) to ensure cell quality, scalability, compatibility with GMP requirements and economic viability for the entire clinical development, including commercialization.
Outlook
WordPress.org
Google Font API
Google Tag Manager
Microsoft Office 365
OVH